Kemal Metin KIR, Nuriye Özlem KÜÇÜK, Elgin ÖZKAN, Çiğdem ÖZKAN

Effect of the application of prophylactic central compartment lymph node dissection on radioiodine ablation doses in patients with papillary thyroid carcinoma

Background/aim: The aim of this study was to document the effect of the application of prophylactic central compartment dissection on radioiodine ablation activities for papillary thyroid carcinoma. Materials and methods: This retrospective study included 452 (383 females, 69 males; mean age = 46.69 years, min max: 13 71) patients who received ablative radioiodine activity between April 2010 and December 2014. The histopathological reports of thyroidectomy and the administered radioiodine activity were evaluated. Frequencies of prophylactic central compartment dissection according to T stage of the primary tumor, detection rate of lymph node metastases, and its effect on radioiodine ablation activities were calculated. Results: Prophylactic central compartment dissection was applied for a total of 252 (56%) patients. The T stages of these patients were T1a, T1b, T2, and T3 in 85 (34%), 106 (42%), 41 (16%), and 20 (8%) cases, respectively. The administered radioiodine ablation activity was affected by central compartment lymph node metastases in 112 (44%) patients. While 32 (29%) of these patients had papillary microcarcinoma (T1a), 48 (43%), 20 (18%), and 12 (11%) of them had T1b, T2, and T3 tumors, respectively. Conclusion: The application of prophylactic central compartment dissection affects the radioiodine ablation activity in approximately half of patients. This effect is more prominent in T1 stage tumors.

PDF

___

1. Shaha AR. Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasis. Surgery 2004; 135: 237-239.
2. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002; 26: 22-28.
3. Yamada K, Tanaka S, Hiratsuka Y, Kumabe Y, Watanabe Y, Yoshida T, Yoshimatsu M. Prognosis of papillary thyroid carcinoma with local invasion. Nihon Jibiinkoka Gakkai Kaiho 2015; 118: 115-122 (in Japanese with English abstract).
4. Chen Q, Zou XH, Wei T, Huang QS, Sun YH, Zhu JQ. Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study. Gland Surg 2015; 4: 288-294.
5. Lan X, Sun W, Zhang H, Dong W, Wang Z, Zhang T. A metaanalysis of central lymph node metastasis for predicting lateral involvement in papillary thyroid carcinoma. Otolaryngol Head Neck Surg 2015; 153: 731-738.
6. Liu J, Xu Z, Li Z, Zhang Z, Tang P, Liu S. Long-term outcomes of observation for clinically negative central compartment lymph nodes in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol 2015; 272: 3801-3804.
7. Mazzaferri EL, Massoll N. Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin. Endocr Relat Cancer 2002; 9: 227-247.
8. Cisco RM, Shen WT, Gosnell JE. Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection. Curr Treat Options Oncol 2012; 13: 1-10.
9. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006; 106: 524-531.
10. Xue S, Wang P, Liu J, Li R, Zhang L, Chen G. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: a retrospective study in China. Asian J Surg (in press).
11. Yan X, Zeng R, Ma Z, Chen C, Chen E, Zhang X, Cao F. The utility of sentinel lymph node biopsy in papillary thyroid carcinoma with occult lymph nodes. PLoS One 2015; 10: e0129304.
12. Ywata de Carvalho A, Chulam TC, Kowalski LP. Long-term results of observation vs. prophylactic selective level VI neck dissection for papillary thyroid carcinoma at a cancer center. JAMA Otolaryngol Head Neck Surg 2015; 141: 599-606.
13. Ahn BH, Kim JR, Jeong HC, Lee JS, Chang ES, Kim YH. Predictive factors of central lymph node metastasis in papillary thyroid carcinoma. Ann Surg Treat Res 2015; 88: 63-68.
14. Qu H, Sun GR, Liu Y, He QS. Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2015; 83: 124-132.
15. Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, Seccia V, Sensi E, Romei C, Piaggi P et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 2015; 100: 1316-1324.
16. Shaha AR. Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery 2009; 146: 1224-1227.
17. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009; 19: 1167-1214.
18. Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP et al. Thyroid carcinoma, version 2.2014. J Natl Compr Canc Netw 2014; 12: 1671-1680.
19. Calò PG, Pisano G, Medas F, Marcialis J, Gordini L, Erdas E, Nicolosi A. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment? World J Surg Oncol 2014; 12: 152.
20. Jiang LH, Chen C, Tan Z, Lu XX, Hu SS, Wang QL, Hou XX, Cao J, Ge MH. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retrospective study of 916 patients. Int J Endocrinol 2014; 2014: 385787.